JESSICA LATHAM: Open Payments
NPI 1619203015 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,004 in 61 payments from 8 companies in 2025. Trend: 2023 $1,136 · 2024 $693 · 2025 $1,004
Food & beverage: $854Consulting: $150
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $453 |
| Axsome Therapeutics, Inc. | 13 | $240 |
| Biogen, Inc. | 2 | $160 |
| UCB, Inc. | 2 | $62 |
| TG Therapeutics, Inc. | 2 | $39 |
| SK Life Science, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| Lilly USA, LLC | 1 | $14 |
Products named: UBRELVY, Symbravo, TYSABRI, QULIPTA, Rystiggo, BRIUMVI, BOTOX, NURTEC ODT.
Industry payments across UT — which companies pay providers there.
